NO20033801L - Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser - Google Patents

Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser

Info

Publication number: NO20033801L
Authority: NO; Norway
Prior art keywords: group; psychotic disorders; phenyl; prevention; treatment
Prior art date: 2001-02-27

Application number

NO20033801A

Other languages

English (en)

Norwegian (no)

Other versions

NO20033801D0 (no

Inventor

Carlos R Plata-Salaman

Boyu Zhao

Roy E Twyman

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-27

Filing date

2003-08-26

Publication date

2003-10-22

2003-08-26 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2003-08-26 Publication of NO20033801D0 publication Critical patent/NO20033801D0/no

2003-10-22 Publication of NO20033801L publication Critical patent/NO20033801L/no

Links

208000028017 Psychotic disease Diseases 0.000 title abstract 2
150000004657 carbamic acid derivatives Chemical class 0.000 title 1
230000002265 prevention Effects 0.000 title 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
229910052794 bromium Inorganic materials 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
239000000460 chlorine Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
229910052731 fluorine Inorganic materials 0.000 abstract 1
239000011737 fluorine Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Psychiatry (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20033801A 2001-02-27 2003-08-26 Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser NO20033801L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US27188901P	2001-02-27	2001-02-27
US10/081,761 US6541513B2 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in preventing or treating psychotic disorders
PCT/US2002/006119 WO2002067927A1 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in preventing or treating psychotic disorders

Publications (2)

Publication Number	Publication Date
NO20033801D0 NO20033801D0 (no)	2003-08-26
NO20033801L true NO20033801L (no)	2003-10-22

Family

ID=26765939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20033801A NO20033801L (no)	2001-02-27	2003-08-26	Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser

Country Status (25)

Country	Link
US (1)	US6541513B2 (cs)
EP (1)	EP1401424B1 (cs)
JP (1)	JP4276841B2 (cs)
KR (1)	KR100886578B1 (cs)
CN (1)	CN1262271C (cs)
AR (1)	AR032876A1 (cs)
AT (1)	ATE346597T1 (cs)
AU (1)	AU2002242296B2 (cs)
BR (1)	BR0207829A (cs)
CA (1)	CA2439480C (cs)
CZ (1)	CZ302412B6 (cs)
DE (1)	DE60216457T2 (cs)
DK (1)	DK1401424T3 (cs)
ES (1)	ES2275844T3 (cs)
HU (1)	HUP0303342A3 (cs)
IL (2)	IL157588A0 (cs)
MX (1)	MXPA03007722A (cs)
NO (1)	NO20033801L (cs)
NZ (1)	NZ527991A (cs)
PL (1)	PL365021A1 (cs)
PT (1)	PT1401424E (cs)
RS (1)	RS51056B (cs)
RU (1)	RU2302240C2 (cs)
TW (1)	TWI251486B (cs)
WO (1)	WO2002067927A1 (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7349301A (en) *	2000-07-21	2002-02-05	Ortho Mcneil Pharm Inc	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
ES2262826T3 (es)	2001-02-27	2006-12-01	Ortho-Mcneil Pharmaceutical, Inc.	Uso de un compuesto de carbamato en la prevencion o el tratamiento de transtornos de ansiedad.
PL364680A1 (en) *	2001-02-27	2004-12-13	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating neurodegenerative disorders
PL368164A1 (en)	2001-07-16	2005-03-21	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
EP1744750A2 (en) *	2004-05-06	2007-01-24	Sandoz AG	Pharmaceutical composition comprising hydrophobic drug having improved solubility
AU2005335241B9 (en) *	2005-07-26	2012-12-20	Sk Biopharmaceuticals Co., Ltd.	Methods for treating substance-related disorders
CA2667949A1 (en) *	2006-10-30	2008-05-08	Janssen Pharmaceutica N.V.	Methods for treating depression
MX2009004798A (es) *	2006-10-31	2009-08-12	Janssen Pharmaceutica Nv	Tratamiento de los trastornos generalizados del desarrollo.
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US9566261B2 (en)	2013-03-12	2017-02-14	Bio-Pharm Solutions Co., Ltd.	Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same
EP2968210B1 (en)	2013-03-12	2024-09-11	Bio-Pharm Solutions Co., Ltd.	Phenyl carbamate compounds for use in preventing or treating pediatric epilesy
KR102900173B1 (ko) *	2016-12-14	2025-12-12	에스케이바이오팜 주식회사	조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US278380A (en) *		1883-05-29		Thermometer
US3313692A (en) *	1958-04-21	1967-04-11	Armour Pharma	Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) *	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
KR0167346B1 (ko) *	1989-06-09	1999-01-15	로버트 에이. 아미테이지	중추신경계 활성을 갖는 헤테로사이클릭 아민
US5492930A (en) *	1994-04-25	1996-02-20	Schering Corporation	Method and formulation for treating CNS disorders
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

2002
- 2002-02-21 US US10/081,761 patent/US6541513B2/en not_active Expired - Lifetime
- 2002-02-21 DK DK02707927T patent/DK1401424T3/da active
- 2002-02-21 BR BR0207829-5A patent/BR0207829A/pt not_active Application Discontinuation
- 2002-02-21 IL IL15758802A patent/IL157588A0/xx unknown
- 2002-02-21 RU RU2003128983/14A patent/RU2302240C2/ru active
- 2002-02-21 AT AT02707927T patent/ATE346597T1/de active
- 2002-02-21 AU AU2002242296A patent/AU2002242296B2/en not_active Ceased
- 2002-02-21 HU HU0303342A patent/HUP0303342A3/hu unknown
- 2002-02-21 PT PT02707927T patent/PT1401424E/pt unknown
- 2002-02-21 RS YUP-675/03A patent/RS51056B/sr unknown
- 2002-02-21 PL PL02365021A patent/PL365021A1/xx unknown
- 2002-02-21 CZ CZ20032297A patent/CZ302412B6/cs not_active IP Right Cessation
- 2002-02-21 NZ NZ527991A patent/NZ527991A/en unknown
- 2002-02-21 MX MXPA03007722A patent/MXPA03007722A/es active IP Right Grant
- 2002-02-21 DE DE60216457T patent/DE60216457T2/de not_active Expired - Lifetime
- 2002-02-21 ES ES02707927T patent/ES2275844T3/es not_active Expired - Lifetime
- 2002-02-21 KR KR1020037011292A patent/KR100886578B1/ko not_active Expired - Lifetime
- 2002-02-21 CN CNB028089235A patent/CN1262271C/zh not_active Expired - Fee Related
- 2002-02-21 CA CA2439480A patent/CA2439480C/en not_active Expired - Fee Related
- 2002-02-21 EP EP02707927A patent/EP1401424B1/en not_active Expired - Lifetime
- 2002-02-21 WO PCT/US2002/006119 patent/WO2002067927A1/en not_active Ceased
- 2002-02-21 JP JP2002567294A patent/JP4276841B2/ja not_active Expired - Lifetime
- 2002-02-27 AR ARP020100702A patent/AR032876A1/es unknown
- 2002-03-05 TW TW091103972A patent/TWI251486B/zh not_active IP Right Cessation
2003
- 2003-08-26 IL IL157588A patent/IL157588A/en not_active IP Right Cessation
- 2003-08-26 NO NO20033801A patent/NO20033801L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CZ302412B6 (cs)	2011-05-04
RS67503A (sr)	2006-12-15
CA2439480A1 (en)	2002-09-06
EP1401424A1 (en)	2004-03-31
AR032876A1 (es)	2003-11-26
CN1505507A (zh)	2004-06-16
CZ20032297A3 (cs)	2004-06-16
JP4276841B2 (ja)	2009-06-10
PT1401424E (pt)	2007-02-28
ES2275844T3 (es)	2007-06-16
BR0207829A (pt)	2004-06-22
US6541513B2 (en)	2003-04-01
HUP0303342A3 (en)	2012-07-30
EP1401424B1 (en)	2006-11-29
NZ527991A (en)	2005-04-29
IL157588A0 (en)	2004-03-28
RU2003128983A (ru)	2005-03-10
RS51056B (sr)	2010-10-31
WO2002067927A1 (en)	2002-09-06
PL365021A1 (en)	2004-12-27
TWI251486B (en)	2006-03-21
NO20033801D0 (no)	2003-08-26
KR100886578B1 (ko)	2009-03-05
IL157588A (en)	2009-12-24
CA2439480C (en)	2011-04-26
MXPA03007722A (es)	2004-11-12
DE60216457T2 (de)	2007-09-20
AU2002242296B2 (en)	2006-06-29
DK1401424T3 (da)	2007-02-26
KR20030076713A (ko)	2003-09-26
JP2004523556A (ja)	2004-08-05
CN1262271C (zh)	2006-07-05
HUP0303342A2 (hu)	2004-01-28
DE60216457D1 (de)	2007-01-11
ATE346597T1 (de)	2006-12-15
US20020165272A1 (en)	2002-11-07
RU2302240C2 (ru)	2007-07-10

Legal Events

Date	Code	Title	Description
2012-10-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
CY1106924T1 (el)	2012-09-26	Ενωσεις καρβαμικου για χρηση οσον αφορα την προληψη ή την αγωγη των διαταραχων κινησης
CY1111349T1 (el)	2015-08-05	Καρβαμιδικες ενωσεις προς χρηση στη θεραπεια του πονου
NO20080877L (no)	2008-02-19	Fremgangsmater for behandling av substansrelaterte forstyrrelser
NO20033801L (no)	2003-10-22	Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser
MY138156A (en)	2009-04-30	Carbamate compounds for use in preventing or treating neurodegenerative disorders
NO20072444L (no)	2007-06-14	Karbamatforbindelser for anvendelse i behandling av neurodegenerative forstyrrelser
NO20033802L (no)	2003-10-22	Karbamatforbindelser for anvendelse ved forebygging eller behandling av bipolar forstyrrelse
NO20033799L (no)	2003-09-10	Karbamatforbindelser for anvendelse ved prevensjon eller terapi av bipolarelidelser
DK1399144T3 (da)	2006-07-24	Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser
NO20040176L (no)	2004-03-12	Karbamatforbindelser for anvendelse ved prevensjon eller terapi av neuropatisk smerte og kluster- og migrenehodepineassosiert smerte
BR0211240A (pt)	2004-07-27	Compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada à cefaléia em cacho e hemicrânia
MY136347A (en)	2008-09-30	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY136733A (en)	2008-11-28	Carbamate compounds for use in preventing or treating psychotic disorders
MY149385A (en)	2013-08-30	Methods for treating substance-related disorders